Oryzon Genomics SA (ORYZF)
3.36
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Oryzon Genomics Total Return Level : 3.36 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 3.36 |
| August 24, 2026 | 3.36 |
| August 21, 2026 | 3.36 |
| August 20, 2026 | 3.36 |
| August 19, 2026 | 3.36 |
| August 18, 2026 | 3.36 |
| August 17, 2026 | 3.36 |
| August 14, 2026 | 3.36 |
| August 13, 2026 | 3.37 |
| August 12, 2026 | 3.37 |
| August 11, 2026 | 3.37 |
| August 10, 2026 | 3.50 |
| August 07, 2026 | 3.50 |
| August 06, 2026 | 3.50 |
| August 05, 2026 | 3.50 |
| August 04, 2026 | 3.50 |
| August 03, 2026 | 3.50 |
| July 31, 2026 | 3.50 |
| July 30, 2026 | 3.45 |
| July 29, 2026 | 3.45 |
| July 28, 2026 | 3.45 |
| July 27, 2026 | 3.45 |
| July 24, 2026 | 3.655 |
| July 23, 2026 | 3.655 |
| July 22, 2026 | 3.655 |
| Date | Value |
|---|---|
| July 21, 2026 | 3.655 |
| July 20, 2026 | 3.655 |
| July 17, 2026 | 3.655 |
| July 16, 2026 | 3.655 |
| July 15, 2026 | 3.655 |
| July 14, 2026 | 3.655 |
| July 13, 2026 | 3.655 |
| July 10, 2026 | 3.655 |
| July 09, 2026 | 3.655 |
| July 08, 2026 | 3.655 |
| July 07, 2026 | 3.655 |
| July 06, 2026 | 3.655 |
| July 02, 2026 | 3.655 |
| July 01, 2026 | 3.655 |
| June 30, 2026 | 3.655 |
| June 29, 2026 | 3.655 |
| June 26, 2026 | 3.645 |
| June 25, 2026 | 3.645 |
| June 24, 2026 | 3.645 |
| June 23, 2026 | 3.645 |
| June 22, 2026 | 3.645 |
| June 18, 2026 | 3.645 |
| June 17, 2026 | 3.645 |
| June 16, 2026 | 3.645 |
| June 15, 2026 | 3.645 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Pharma Mar SA | 95.05 |
| Grifols SA | 9.880 |
| ACADIA Pharmaceuticals, Inc. | 30.57 |
| Alkermes Plc | 49.21 |
| Alnylam Pharmaceuticals, Inc. | 240.08 |